NDC 61755-027
Imdevimab
Imdevimab
Imdevimab is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Regeneron Pharmaceuticals, Inc.. The primary component is Imdevimab.
| Product ID | 61755-027_1b115152-c792-4dbd-aede-52dc7fdf8436 |
| NDC | 61755-027 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Imdevimab |
| Generic Name | Imdevimab |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-11-21 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Regeneron Pharmaceuticals, Inc. |
| Substance Name | IMDEVIMAB |
| Active Ingredient Strength | 300 mg/2.5mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |